CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-06 | Nash Huw M. COO & CBO | Sale | −32 | $57.14 | $2K | 0 |
| 2021-01-04 | Nash Huw M. COO & CBO | Exercise or conversion | +5,700 | $2.19 | $12K | 5,732 |
| 2021-01-04 | Nash Huw M. COO & CBO | Sale | −1,500 | $57.66 | $86K | 4,232 |
| 2021-01-04 | Nash Huw M. COO & CBO | Sale | −2,200 | $59.02 | $130K | 2,032 |
| 2021-01-04 | Nash Huw M. COO & CBO | Sale | −1,800 | $59.85 | $108K | 232 |
| 2021-01-04 | Nash Huw M. COO & CBO | Sale | −200 | $60.51 | $12K | 32 |
| 2021-01-04 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −5,700 | 125,397 | ||
| 2020-12-30 | Kaye Edward M. MD CEO | Exercise or conversion | +10,000 | $0.60 | $6K | 10,000 |
| 2020-12-30 | Kaye Edward M. MD CEO | Exercise or conversion · Employee Stock Option (right to buy) | −10,000 | 637,801 | ||
| 2020-12-28 | Liau Gene EVP Research & Preclinical Dev | Exercise or conversion | +8,000 | $0.60 | $5K | 21,500 |
| 2020-12-28 | Liau Gene EVP Research & Preclinical Dev | Sale | −149 | $58.73 | $9K | 21,351 |
| 2020-12-28 | Liau Gene EVP Research & Preclinical Dev | Exercise or conversion · Employee Stock Option (right to buy) | −8,000 | 88,069 | ||
| 2020-12-21 | Ticho Barry Chief Medical Officer | Exercise or conversion | +1,365 | $2.19 | $3K | 174,767 |
| 2020-12-21 | Ticho Barry Chief Medical Officer | Sale | −714 | $56.76 | $41K | 174,053 |
| 2020-12-21 | Ticho Barry Chief Medical Officer | Sale | −286 | $58.02 | $17K | 173,767 |
| 2020-12-21 | Ticho Barry Chief Medical Officer | Sale | −365 | $59.00 | $22K | 173,402 |
| 2020-12-21 | Ticho Barry Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −1,365 | 84,400 | ||
| 2020-12-18 | Nash Huw M. COO & CBO | Exercise or conversion | +8,015 | $0.60 | $5K | 8,015 |
| 2020-12-18 | Nash Huw M. COO & CBO | Sale | −8,015 | $60.00 | $481K | 0 |
| 2020-12-18 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −8,015 | 172,371 |
Page 26 of 35 · 681 trades